未登录

N

Niranjan B. Pandey

Johns Hopkins University

H指数:23

被引数:1,878

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of a Highly Potent and Selective Oncolytic Peptide NF27 through Structure−Activity Relationship Studies

通过构效关系研究发现的具有高活性和选择性的溶瘤肽NF27

Journal of Medicinal Chemistry

IF6.8

2026-01-010

PRE

Chemokine-derived oncolytic peptide induces immunogenic cancer cell death and significantly suppresses tumor growth

CELL DEATH DISCOVERY

IF7

2024-04-021

OAAI

Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide

新型肽对TNBC小鼠模型中肿瘤免疫微环境和血管正常化的调节

IF6.3

2020-05-1416

OAAI

Cytokines secreted by stromal cells in TNBC microenvironment as potential targets for cancer therapy

CANCER BIOLOGY & THERAPY

IF4.6

2020-03-2622

OAAI

Anisotropic poly(lactic-co-glycolic acid) microparticles enable sustained release of a peptide for long-term inhibition of ocular neovascularization

各向异性聚 (乳酸-共-乙醇酸) 微粒能够持续释放肽，以长期抑制眼部新血管形成

ACTA BIOMATERIALIA

IF9.6

2019-10-0117

OAAI

Mechanistically detailed systems biology modeling of the HGF/Met pathway in hepatocellular carcinoma

NPJ SYSTEMS BIOLOGY AND APPLICATIONS

IF3.5

2019-08-1620

OAAI

Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE

IF4.7

2018-10-3027

OAAI

Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis

BREAST CANCER RESEARCH

IF5.6

2018-06-1471

OAAI

Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells

从聚合物纳米颗粒表面显示的仿生肽，用于对人三阴性乳腺癌细胞的靶向和抗肿瘤活性

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A

IF3.9

2018-02-2337

OAAI

Therapeutic potential of antiangiogenic multimodal biomimetic peptide in hepatocellular carcinoma

CANCER RESEARCH

IF16.6

2017-07-010

PRE

IL-8 signaling enhances TNBC growth and metastasis via crosstalk with stromal components

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage

SCIENCE TRANSLATIONAL MEDICINE

IF14.6

2017-01-1850

OAAI

Crosstalk between TNBC and stromal components via secreted factors enhances cell motility that can be attenuated by a CXCR1 inhibitor

CANCER RESEARCH

IF16.6

2016-07-150

PRE

Analysis of gene expression of secreted factors associated with breast cancer metastases in breast cancer subtypes

SCIENTIFIC REPORTS

IF3.9

2015-07-1542

OAAI

Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis

NATURE COMMUNICATIONS

IF15.7

2014-09-02170

OAAI

Lymphatic endothelial cells support tumor growth in breast cancer

SCIENTIFIC REPORTS

IF3.9

2014-07-2859

OAAI

Lymphatic endothelium promotes angiogenesis, tumor growth, and metastasis in breast cancer

CANCER RESEARCH

IF16.6

2014-05-010

PRE

Long-term suppression of ocular neovascularization by intraocular injection of biodegradable polymeric particles containing a serpin-derived peptide

IF12.9

2013-10-0158

OAAI

Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model

CLINICAL & EXPERIMENTAL METASTASIS

IF3.2

2013-08-2120

OA

Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45A

IF7.7

2013-02-0146

OAAI